NIH-funded research Fellowship grant

Understanding how Caspase-8 affects cancer and immune responses

Official title: THE FUNCTION OF CASPASE-8 IN CANCER, ANTI-CANCER IMMUNITY, AND CAR-T CELL FUNCTION

Funded at St. Jude Children's Research Hospital · NIH-10999086 · Data updated 2026-11-12

This study is looking at how a protein called Caspase-8 affects T cells and inflammation in cancer, which could help us understand how to make cancer treatments, like CAR-T cell therapy, work better for patients.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionSt. Jude Children's Research Hospital
NIH-funded
Lab location1 site (Memphis, United States)
Project startJuly 1, 2024
Project endApril 30, 2026
Funding year2024
Award (this year)$76,756
NIH project number1F32CA291105-01A1
Project IDNIH-10999086 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include adults with various cancers, particularly those undergoing or considering CAR-T cell therapy.

Less likely to help

Patients with cancers that do not involve the Caspase-8 pathway or those who are not eligible for CAR-T cell therapy may not benefit from this research.

What this research studies

This research investigates the role of Caspase-8, a protein involved in cell death, in cancer and the immune system. It aims to explore how Caspase-8 influences T cell function and inflammatory responses in the context of cancer. By comparing cancer cells with and without Caspase-8, the research will assess its impact on tumor growth and the effectiveness of CAR-T cell therapy. This could lead to new insights into improving cancer treatments and enhancing anti-cancer immunity.

Why it matters

Potential benefit: If successful, this research could lead to improved cancer therapies and enhanced effectiveness of immunotherapies like CAR-T cell treatment.

How similar studies have gone: Previous research has shown promising results in understanding the role of apoptotic proteins in cancer, suggesting that this approach could yield valuable insights.

Where this research is happening

  • St. Jude Children's Research Hospital
    Memphis, United States
    Active

Researchers

  • Principal investigator: Shaw, Jeremy Joseph Porter — St. Jude Children's Research Hospital
  • Study coordinator: Shaw, Jeremy Joseph Porter

Related research

Other NIH-funded projects on the same topics.

  • Investigating frailty and aging in childhood cancer survivors

    This study is looking at childhood cancer survivors to see how they might face health challenges similar to older adults as they grow up, and it aims to find ways to help them stay strong and healthy by exploring treatments that could improve their well-being.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-9890475

  • Investigating a specific type of leukemia in children caused by genetic changes.

    This study is looking at how certain proteins linked to leukemia affect kids and teens with high-risk blood cancers, and the researchers hope to find new ways to treat these conditions by learning more about how the disease works.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-9834651

  • Accessible, label-free optical imaging to reveal disease signals

    A brain-friendly, patient-centered imaging approach aims to uncover hidden disease signals in cells and tissues without labels or dyes.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-11627327

  • Targeting the SCP4 pathway in acute myeloid leukemia (AML)

    Aims to uncover how the SCP4 signaling pathway drives AML and how it could be blocked to help patients.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-11617813

  • Blocking cancer-causing cMYC tricks after pregnancy changes in the breast

    Researchers are testing how pregnancy and aging reshape the breast before cancer risk, using patient-reinformed models to see if it changes how dangerous cMYC signals behave.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-11615605

  • Targeting aberrant enhancer landscapes in pancreatic cancer

    A patient-facing look at a project that aims to understand how pancreatic cancer changes its cell identity and what that means for treatment.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-11611138

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.